The NITRO program funds research to develop new therapeutics that stimulate the body's biological repair mechanisms to heal damaged cartilage and bone in osteoarthritis. It supports injectable bone and cartilage regeneratives and replacement joints made from patients' own cells that are load-bearing and non-immunogenic. The program emphasizes collaborative, multidisciplinary approaches to improve treatment accessibility and outcomes across the U.S.
Eligibility criteria are not specified in the available information.
